Bausch + Lomb reports positive study results for Blink NutriTears

seekingalpha04-26

Bausch + Lomb (NYSE:BLCO) said a study for its new nutritional supplement for dry eyes met its primary endpoints of change in tear production and participant reports of dry eye symptoms. The study was...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2430231832?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/169595331/image_169595331.jpg","is_english":true,"pubTime":"2024-04-26 00:33","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2430231832","market":"sg","top_or_hot":-1,"title":"Bausch + Lomb reports positive study results for Blink NutriTears","media":"seekingalpha","content":"<div>\n<p>Bausch + Lomb (NYSE:BLCO) said a study for its new nutritional supplement for dry eyes met its primary endpoints of change in tear production and participant reports of dry eye symptoms. The study was...</p>\n\n<a href=\"https://seekingalpha.com/news/4094283-bausch-lomb-reports-positive-study-results-for-blink-nutritears\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bausch + Lomb reports positive study results for Blink NutriTears</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBausch + Lomb reports positive study results for Blink NutriTears\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-26 00:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4094283-bausch-lomb-reports-positive-study-results-for-blink-nutritears><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Bausch + Lomb (NYSE:BLCO) said a study for its new nutritional supplement for dry eyes met its primary endpoints of change in tear production and participant reports of dry eye symptoms. The study was...</p>\n\n<a href=\"https://seekingalpha.com/news/4094283-bausch-lomb-reports-positive-study-results-for-blink-nutritears\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://seekingalpha.com/news/4094283-bausch-lomb-reports-positive-study-results-for-blink-nutritears","article_id":"2430231832","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/169595331/image_169595331.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2430231832","pubTimestamp":1714062820,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Bausch + Lomb  said a study for its new nutritional supplement for dry eyes met its primary endpoints of change in tear production and participant reports of dry eye symptoms. The study was published in the journal Frontiers in Ophthalmology. The eyecare company said it plans to launch the product in the US under the brand name Blink NutriTears in early Q3.  Bausch + Lomb was spun out of Bausch Health  as a separately traded company in 2022.  More on Bausch + Lomb  Bausch + Lomb Corporation  Q4 2023 Earnings Call Transcript Bausch + Lomb Corporation 2023 Q4 - Results - Earnings Call Presentation Hovering Around 52-Week Low, Bausch + Lomb May Be Poised For A Rebound Emergent surges 66% as it brings in Bausch + Lomb vet Papa as CEO Bausch + Lomb gains after earnings beat","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4198":"医疗保健用品","BLCO":"博士伦","BHC":"Bausch Health Companies Inc","BK4007":"制药"},"translate_title":"Bausch+Lomb报告Blink NutriTears的积极研究结果","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BHC":1,"BLCO":1},"content_text":"Bausch + Lomb (NYSE:BLCO) said a study for its new nutritional supplement for dry eyes met its primary endpoints of change in tear production and participant reports of dry eye symptoms. The study was published in the journal Frontiers in Ophthalmology. The eyecare company said it plans to launch the product in the US under the brand name Blink NutriTears in early Q3.  Bausch + Lomb was spun out of Bausch Health (BHC) as a separately traded company in 2022.  More on Bausch + Lomb  Bausch + Lomb Corporation (BLCO) Q4 2023 Earnings Call Transcript Bausch + Lomb Corporation 2023 Q4 - Results - Earnings Call Presentation Hovering Around 52-Week Low, Bausch + Lomb May Be Poised For A Rebound Emergent surges 66% as it brings in Bausch + Lomb vet Papa as CEO Bausch + Lomb gains after earnings beat","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2430231832"}